C Difficile

9822 bookmarks
Newest
A conserved switch controls virulence, sporulation, and motility in C. difficile - PubMed
A conserved switch controls virulence, sporulation, and motility in C. difficile - PubMed
Spore formation is required for environmental survival and transmission of the human enteropathogenic Clostridioides difficile. In all bacterial spore formers, sporulation is regulated through activation of the master response regulator, Spo0A. However, the factors and mechanisms that directly regul …
·pubmed.ncbi.nlm.nih.gov·
A conserved switch controls virulence, sporulation, and motility in C. difficile - PubMed
Clostridium Difficile Infections Treatment Market is set to Reach US$ 1,727.1 million at a CAGR of 6.8% from the forecast period 2023 to 2031 | Growth Plus Reports
Clostridium Difficile Infections Treatment Market is set to Reach US$ 1,727.1 million at a CAGR of 6.8% from the forecast period 2023 to 2031 | Growth Plus Reports
Pune, Feb. 19, 2024 (GLOBE NEWSWIRE) -- According to the latest report published by Growth Plus Reports, the global Clostridium Difficile Infections Treatment Market is expected to clock US$ 1,727.1 million by 2031 and to grow at a CAGR of 6.8% during the forecast period. The global Clostridium difficile Infections (CDI) Treatment Market is witnessing significant growth, driven by the rising incidence of CDI, increasing antibiotic resistance, and the demand for effective treatment options to com
·news.google.com·
Clostridium Difficile Infections Treatment Market is set to Reach US$ 1,727.1 million at a CAGR of 6.8% from the forecast period 2023 to 2031 | Growth Plus Reports
Efficacy and regulatory strategies of gut microbiota in immunotherapy: a narrative review - PubMed
Efficacy and regulatory strategies of gut microbiota in immunotherapy: a narrative review - PubMed
The abundance and proportion of intestinal microorganisms influence the susceptibility of tumors to tumor immunotherapy. This article reviewed the effects and mechanisms of gut microbes on tumor immunotherapy to further explore the medical value of gut microbes in tumor immunotherapy.
·pubmed.ncbi.nlm.nih.gov·
Efficacy and regulatory strategies of gut microbiota in immunotherapy: a narrative review - PubMed
The dual role of 20(S)-protopanaxadiol in alleviating pulmonary fibrosis through the gut-lung axis - PubMed
The dual role of 20(S)-protopanaxadiol in alleviating pulmonary fibrosis through the gut-lung axis - PubMed
This study positions PPD as a vanguard in the therapeutic landscape for pulmonary fibrosis, offering a dual mechanism of action that encompasses both modulation of gut microbiota and direct intervention at molecular targets. These insights highlight the immense therapeutic potential of harnessing th …
·pubmed.ncbi.nlm.nih.gov·
The dual role of 20(S)-protopanaxadiol in alleviating pulmonary fibrosis through the gut-lung axis - PubMed
Achyranthes bidentata polysaccharide ameliorates type 2 diabetes mellitus by gut microbiota-derived short-chain fatty acids-induced activation of the GLP-1/GLP-1R/cAMP/PKA/CREB/INS pathway - PubMed
Achyranthes bidentata polysaccharide ameliorates type 2 diabetes mellitus by gut microbiota-derived short-chain fatty acids-induced activation of the GLP-1/GLP-1R/cAMP/PKA/CREB/INS pathway - PubMed
Gut microbiota variances reflecting the severity type 2 diabetes mellitus (T2DM). Achyranthes bidentata polysaccharide (ABP) can regulate gut microbiota. However, the hypoglycemic effect and underlying mechanism of ABP remain unclear. Herein, we characterized the structure of ABP and revealed the hy …
·pubmed.ncbi.nlm.nih.gov·
Achyranthes bidentata polysaccharide ameliorates type 2 diabetes mellitus by gut microbiota-derived short-chain fatty acids-induced activation of the GLP-1/GLP-1R/cAMP/PKA/CREB/INS pathway - PubMed
The Importance of Microbiota and Fecal Microbiota Transplantation in Pancreatic Disorders - PubMed
The Importance of Microbiota and Fecal Microbiota Transplantation in Pancreatic Disorders - PubMed
The role of the intestinal microbiota in the diagnosis and treatment of pancreatic diseases is increasingly significant. Consequently, fecal microbiota transplantation (FMT) is emerging as a promising therapeutic avenue for various pancreatic disorders, including cancer, pancreatitis, and type 1 dia …
·pubmed.ncbi.nlm.nih.gov·
The Importance of Microbiota and Fecal Microbiota Transplantation in Pancreatic Disorders - PubMed
Sea Buckthorn Polysaccharide Ameliorates Colitis - PubMed
Sea Buckthorn Polysaccharide Ameliorates Colitis - PubMed
Ulcerative colitis (UC) is characterized by chronic inflammation and ulceration of the intestinal inner lining, resulting in various symptoms. Sea buckthorn berries contain a bioactive compound known as sea buckthorn polysaccharide (SBP). However, the precise mechanisms underlying the impact of SBP …
·pubmed.ncbi.nlm.nih.gov·
Sea Buckthorn Polysaccharide Ameliorates Colitis - PubMed
Anti-inflammatory Effects of Bacteroidota Strains Derived From Outstanding Donors of Fecal Microbiota Transplantation for the Treatment of Ulcerative Colitis - PubMed
Anti-inflammatory Effects of Bacteroidota Strains Derived From Outstanding Donors of Fecal Microbiota Transplantation for the Treatment of Ulcerative Colitis - PubMed
This study demonstrated that A. putredinis, a representative Bacteroidota species, exhibits anti-inflammatory effects in vivo and in vitro; however, the effects of other Bacteroidota species remain unexplored. Our fecal microbiota transplantation-based reverse translation approach using promising ba …
·pubmed.ncbi.nlm.nih.gov·
Anti-inflammatory Effects of Bacteroidota Strains Derived From Outstanding Donors of Fecal Microbiota Transplantation for the Treatment of Ulcerative Colitis - PubMed
Fighting against Clostridioides difficile infection: Current medications - PubMed
Fighting against Clostridioides difficile infection: Current medications - PubMed
Clostridioides difficile (formerly Clostridium difficile) has been regarded as an "urgent threat" and a significant global health problem, as life-threatening diarrhea and refractory recurrence are common in patients with C. difficile infection (CDI). Unfortunately, the available anti-CDI drugs are …
·pubmed.ncbi.nlm.nih.gov·
Fighting against Clostridioides difficile infection: Current medications - PubMed
Mechanisms of microbiota modulation: Implications for health, disease, and therapeutic interventions - PubMed
Mechanisms of microbiota modulation: Implications for health, disease, and therapeutic interventions - PubMed
Microbiota modulation, the intentional change in the structure and function of the microbial community, is an emerging trajectory that holds the promise to mitigate an infinite number of health issues. The present review illustrates the underlying principles of microbiota modulation and the various …
·pubmed.ncbi.nlm.nih.gov·
Mechanisms of microbiota modulation: Implications for health, disease, and therapeutic interventions - PubMed
Clostridioides Difficile: A Concise Review of Best Practices and Updates - PubMed
Clostridioides Difficile: A Concise Review of Best Practices and Updates - PubMed
Clostridioides difficile infection (CDI) is one of the most common and severe nosocomial infections worldwide. It can also affect healthy individuals in the community. The incidence of CDI has been on the rise globally for the past decade, necessitating a proactive approach to combat its spread; new …
·pubmed.ncbi.nlm.nih.gov·
Clostridioides Difficile: A Concise Review of Best Practices and Updates - PubMed
Comparison of fidaxomicin, thuricin CD, vancomycin and nisin highlights the narrow spectrum nature of thuricin CD - PubMed
Comparison of fidaxomicin, thuricin CD, vancomycin and nisin highlights the narrow spectrum nature of thuricin CD - PubMed
Vancomycin and metronidazole are commonly used treatments for Clostridioides difficile infection (CDI). However, these antibiotics have been associated with high levels of relapse in patients. Fidaxomicin is a new treatment for CDI that is described as a narrow spectrum antibiotic that is min …
·pubmed.ncbi.nlm.nih.gov·
Comparison of fidaxomicin, thuricin CD, vancomycin and nisin highlights the narrow spectrum nature of thuricin CD - PubMed
Exploring toilet plume bioaerosol exposure dynamics in public toilets using a Design of Experiments approach - PubMed
Exploring toilet plume bioaerosol exposure dynamics in public toilets using a Design of Experiments approach - PubMed
Bioaerosols generated during toilet flushing can contribute to the spread of airborne pathogens and cross-contamination in indoor environments. This presents an increased risk of fomite-mediated or aerosol disease transmission. This study systematically investigated the factors contributing to incre …
·pubmed.ncbi.nlm.nih.gov·
Exploring toilet plume bioaerosol exposure dynamics in public toilets using a Design of Experiments approach - PubMed
Cu exposure induces liver inflammation via regulating gut microbiota/LPS/liver TLR4 signaling axis - PubMed
Cu exposure induces liver inflammation via regulating gut microbiota/LPS/liver TLR4 signaling axis - PubMed
Copper (Cu) serves as an essential cofactor in all organisms, yet excessive Cu exposure is widely recognized for its role in inducing liver inflammation. However, the precise mechanism by which Cu triggers liver inflammation in ducks, particularly in relation to the interplay in gut microbiota regul …
·pubmed.ncbi.nlm.nih.gov·
Cu exposure induces liver inflammation via regulating gut microbiota/LPS/liver TLR4 signaling axis - PubMed
Antibiotic-associated Gut Dysbiosis - PubMed
Antibiotic-associated Gut Dysbiosis - PubMed
The human gut microbiota plays a crucial role in maintaining overall health. However, the widespread use of antibiotics has raised concerns about its impact on the microbial ecosystem. This review explores the multifaceted relationship between antibiotics and gut dysbiosis, highlighting the mechanis …
·pubmed.ncbi.nlm.nih.gov·
Antibiotic-associated Gut Dysbiosis - PubMed
Effects of prednisolone tapering on effectiveness of infliximab in patients with ulcerative colitis: data from a retrospective cohort - PubMed
Effects of prednisolone tapering on effectiveness of infliximab in patients with ulcerative colitis: data from a retrospective cohort - PubMed
In UC patients with limited disease burden, prednisolone did not affect effectiveness of infliximab. However, patients with increased disease burden seem to benefit from corticosteroid combination therapy.
·pubmed.ncbi.nlm.nih.gov·
Effects of prednisolone tapering on effectiveness of infliximab in patients with ulcerative colitis: data from a retrospective cohort - PubMed
Defining the phylogenetics and resistome of the major Clostridioides difficile ribotypes circulating in Australia - PubMed
Defining the phylogenetics and resistome of the major Clostridioides difficile ribotypes circulating in Australia - PubMed
Clostridioides difficile infection (CDI) remains a significant public health threat globally. New interventions to treat CDI rely on an understanding of the evolution and epidemiology of circulating strains. Here we provide longitudinal genomic data on strain diversity, transmission dynamics …
·pubmed.ncbi.nlm.nih.gov·
Defining the phylogenetics and resistome of the major Clostridioides difficile ribotypes circulating in Australia - PubMed
Fecal microbiota transplantation: current challenges and future landscapes - PubMed
Fecal microbiota transplantation: current challenges and future landscapes - PubMed
SUMMARYGiven the importance of gut microbial homeostasis in maintaining health, there has been considerable interest in developing innovative therapeutic strategies for restoring gut microbiota. One such approach, fecal microbiota transplantation (FMT), is the main "whole gut microbiome replacement" …
·pubmed.ncbi.nlm.nih.gov·
Fecal microbiota transplantation: current challenges and future landscapes - PubMed
Secondary prophylaxis for Clostridioides difficile infection for patients on non- Clostridioides difficile antibiotics: A retrospective cohort study - PubMed
Secondary prophylaxis for Clostridioides difficile infection for patients on non- Clostridioides difficile antibiotics: A retrospective cohort study - PubMed
Secondary prophylaxis with CDI antibiotics appears to be associated with a reduced risk of recurrence in patients with previous non-severe CDI episode. Further studies are needed to confirm this finding.
·pubmed.ncbi.nlm.nih.gov·
Secondary prophylaxis for Clostridioides difficile infection for patients on non- Clostridioides difficile antibiotics: A retrospective cohort study - PubMed
Role of gut microbiota in doxorubicin-induced cardiotoxicity: from pathogenesis to related interventions - PubMed
Role of gut microbiota in doxorubicin-induced cardiotoxicity: from pathogenesis to related interventions - PubMed
Doxorubicin (DOX) is a broad-spectrum and highly efficient anticancer agent, but its clinical implication is limited by lethal cardiotoxicity. Growing evidences have shown that alterations in intestinal microbial composition and function, namely dysbiosis, are closely linked to the progression of DO …
·pubmed.ncbi.nlm.nih.gov·
Role of gut microbiota in doxorubicin-induced cardiotoxicity: from pathogenesis to related interventions - PubMed
Validation of clinical risk tools for recurrent Clostridioides difficile infection - PubMed
Validation of clinical risk tools for recurrent Clostridioides difficile infection - PubMed
All tools performed poorly for predicting recurrent C. difficile infection (AUROC range: 0.488-0.564), especially among patients with a prior history of infection (AUROC range: 0.436-0.591). Future studies may benefit from considering novel biomarkers and/or higher-dimensional models that cou …
·pubmed.ncbi.nlm.nih.gov·
Validation of clinical risk tools for recurrent Clostridioides difficile infection - PubMed
Improvements in Gut Microbiome Composition and Clinical Symptoms Following Familial Fecal Microbiota Transplantation in a Nineteen-Year-Old Adolescent With Severe Autism - PubMed
Improvements in Gut Microbiome Composition and Clinical Symptoms Following Familial Fecal Microbiota Transplantation in a Nineteen-Year-Old Adolescent With Severe Autism - PubMed
This case report describes a novel therapy for patients with severe autism spectrum disorder (ASD) that is worth further investigation. A 19-year-old male adolescent with ASD, who was not responding to standard treatment received fecal microbiota transplant (FMT) using donor material from his typica …
·pubmed.ncbi.nlm.nih.gov·
Improvements in Gut Microbiome Composition and Clinical Symptoms Following Familial Fecal Microbiota Transplantation in a Nineteen-Year-Old Adolescent With Severe Autism - PubMed